Literature DB >> 3537181

Two-dimensional and three-dimensional movement of human polymorphonuclear leukocytes: two fundamentally different mechanisms of locomotion [corrected].

F C Schmalstieg, H E Rudloff, G R Hillman, D C Anderson.   

Abstract

Patients with an inherited deficiency of the adherence glycoproteins LFA-1, Mac-1, and p150,95 are unable to mobilize polymorphonuclear leukocytes (PMNLs) to peripheral sites of inflammation. LFA-1/Mac-1/p150,95-deficient PMNL exhibited profoundly impaired movement stimulated by chemotactic factors when the cells were required to move over two-dimensional surfaces. Less impairment of movement was demonstrated in three-dimensional movement through cellulose filters. A possible explanation for this difference in cell translational mobility is that movement in cellulose filters is less adherence dependent than movement over a two-dimensional plastic surface. Movement of PMNL in collagen gels is known to be relatively independent of adherence. No deficiency of translational mobility of PMNL from LFA-1/Mac-1/p150,95-deficient patients was observed in collagen gels. Antibodies against the common beta subunit effectively blocked two-dimensional movement but had little effect on three-dimensional movement through cellulose filters or collagen gel matrices. HL-60 cells were employed as a model to investigate the effects of adherence on cell movement. Treatment of HL-60 cells with phorbol myristate acetate resulted in the appearance of Mac-1 and p150,95 on the cell surface. Concurrently, the cells exhibited increased adherence to glass and plastic. In spite of increased adherence, HL-60 cells showed no translational movement, indicating factors other than the ability to adhere were important in cell motility. These experiments implied that PMNLs undergo two fundamentally different kinds of motion, one adherence dependent (two-dimensional movement) and the other largely adherence independent (three-dimensional movement). These findings are consistent with the view that egress of PMNLs from the vascular space is adherence dependent. Movement through extravascular tissues may be adherence independent.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3537181     DOI: 10.1002/jlb.40.6.677

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  6 in total

1.  Characterizing natural hydrogel for reconstruction of three-dimensional lymphoid stromal network to model T-cell interactions.

Authors:  Jiwon Kim; Biming Wu; Steven M Niedzielski; Matthew T Hill; Rhima M Coleman; Akira Ono; Ariella Shikanov
Journal:  J Biomed Mater Res A       Date:  2015-02-15       Impact factor: 4.396

2.  Dendritic cell chemotaxis in 3D under defined chemokine gradients reveals differential response to ligands CCL21 and CCL19.

Authors:  Ulrike Haessler; Marco Pisano; Mingming Wu; Melody A Swartz
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-21       Impact factor: 11.205

3.  Random locomotion and chemotaxis of human blood polymorphonuclear leukocytes (PMN) in the presence of EDTA: PMN in close quarters require neither leukocyte integrins nor external divalent cations.

Authors:  S E Malawista; A de Boisfleury Chevance
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

4.  Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro.

Authors:  C W Smith; S D Marlin; R Rothlein; C Toman; D C Anderson
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

5.  Recruitment of CD11b/CD18 to the neutrophil surface and adherence-dependent cell locomotion.

Authors:  B J Hughes; J C Hollers; E Crockett-Torabi; C W Smith
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

6.  The 5-Phosphatase SHIP2 Promotes Neutrophil Chemotaxis and Recruitment.

Authors:  Melina Michael; Barry McCormick; Karen E Anderson; Utsa Karmakar; Matthieu Vermeren; Stéphane Schurmans; Augustin Amour; Sonja Vermeren
Journal:  Front Immunol       Date:  2021-04-19       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.